Today's top medical abstracts
Oncology
Become a Member Today!
Email
Password
Remember me
Forgot your Password?

Invite Code?

Home
General Oncology
For Practicing
Oncologists
Conferences
Jobs
Newsletters
My Library
Topics in
Oncology
        Alternative Therapies
        Anemia/Polycythemia
        BMT/SCT
        Basic Science/Genetics
        Bone/Cartilage
        Breast
        Carcinogenesis
        Coagulation/Bleeding Dz
        Colorectal Cancer/Polyps
        Dermatologic Oncology
        Diagnostics/Radiology
        Economics of Medicine
        Endocrine Oncology
        GI Oncology
        Gynecologic Oncology
        Head and Neck
        Hepatobiliary/Pancreas
        Leukemia/Lymphoma
        Lung/Thoracic Oncology
        Myeloproliferative Dz
        Neurologic Oncology
        Pain/Palliative Care
        Pediatric Heme/Oncology
        Pharmacology/Therapy
        Popular Press
        Renal/Urologic
        Side Effects
        Soft Tissue/Sarcoma
        Transfusion Medicine
 
Help
Resource Center
RSS News Feeds
Send Newsletter
to a Friend
 
Sponsor
For Practicing Oncologists
Improving Your Bottom Line: Mid Year Analysis Vital to Practice
Owen Dahl, Owen Dahl Consulting
FDA Update: Immune Response Robustness Correlates with Survival in Brain Cancer Vaccine Trial
Tracy Hampton, PhD, MDLinx Oncology
  See all
hereditary breast-ovarian cancer syndrome;prophylactic surgical management Article Summary

Click the title below to leave the MDLinx Network and go to the Journal's Website
Coordinated prophylactic surgical management for women with hereditary breast-ovarian cancer syndrome
BMC Cancer, 04/18/08
Print     Email This Article     Save in My Library   Free Abstract
Batista LI et al. - In a trial to assess the feasibility of coordinated prophylactic mastectomy (PM) and bilateral salpingo-oophorectomy (BSO) in hereditary breast-ovarian cancer syndrome, it was shown that coordinated PM and BSO is a feasible procedure with acceptable morbidity in selected high-risk pts that desire to undergo surgery at 1 operative setting

Methods
  • High-risk women for breast and ovarian cancer who underwent coordinated PM and BSO were included
  • Clinical characteristics and surgical and oncologic outcomes were retrospectively reviewed

Results
  • 12 pts underwent coordinated PM and BSO; 10 had history of previous breast cancer
  • Autologous breast reconstruction was performed in 10 pts
  • Mean age at surgery was 43; mean operating time was 9.3 hours with a mean postoperative hospitalization of 5.4 days
  • Postoperatively, 1 pt developed an abdominal wound dehiscence, another reoperation for flap congestion; 1 had umbilical superficial epidermolysis, and 1 developed aspiration pneumonia
  • At a mean follow-up of 84 months, 10 pts were cancer-free
  • Although no pts developed a new primary cancer, 2 developed a distant recurrence

Sponsor
Read a Different Specialty
Allergy/Immunology
Anesthesiology
Cardiology
Dermatology
Drugs
Emergency Medicine
Endocrinology
ENT
Family Medicine
Gastroenterology
Hematology-Oncology
Infectious Disease
Internal Medicine
Nephrology
Neurology
OB/Gyn
Ophthalmology
Orthopedics
Pediatrics
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology
Profession Index
Dentist
Hospital Administrator
Nurse
    Medical Students
Nurse Practitioner
Pharma/Drug Marketer
    Pharmacist
Physician
Physician Assistants
Article Search
Keyword:
Search:
Published within:
Sort By:
Date Relevance
    
Sponsor
Sponsor
About MDLinx  |  Contact  |  Advertise with MDLinx  |  Site Map  |  Privacy Policy  |  Terms of Use  |  Sign Up For Newsletters  |  Recommend this Site

English |  Español |  Français |  Deutsch |  中文 |  Руccкий |  Norsk |  Nederlands |  Português |  Italiano

©1999-2008 MDLinx, Inc.